NCT04776395 2026-04-17
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
Emory University
Phase 2 Recruiting
Clinical Trials
10 trialsNCT05272826 2026-03-18
BOREALIS
Canadian Myeloma Research Group
Phase 2 Recruiting
NCT05896228 2026-03-11
Iber-KDd
University of Miami
Phase 2 Recruiting
NCT06762769 2025-08-01
MODIFY
University College, London
Phase 2 Recruiting
NCT05354557 2025-05-18
Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT05177536 2025-05-13
Iberdomide Maintenance Therapy in Patients With Multiple Myeloma
University of Nebraska
Phase 2 Active not recruiting
NCT04998786 2025-04-06
I2D IFM2021_03
Nantes University Hospital
Phase 2 Active not recruiting
NCT04392037 2025-03-28
ICON
Amsterdam UMC, location VUmc
Phase 2 Active not recruiting
NCT06107738 2025-01-09
IBEX
Barbara Ann Karmanos Cancer Institute
Phase 2 Recruiting
NCT05527340 2022-09-02
Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.
PETHEMA Foundation
Phase 2 Not yet recruiting